Related Experiment Video
Updated: Aug 11, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages
Amy O Hardin1, Elizabeth A Meals, Taolin Yi
1Children's Foundation Research Center at Le Bonheur Children's Medical Center, Room 301 West Patient Tower, 50 North Dunlap, Memphis, TN 38103, USA.
Abstract:
Several lines of evidence have suggested that protein tyrosine phosphatases, including CD45 and SHP-1, regulate macrophage activation. Macrophages from mice lacking SHP-1 (motheaten mice) are hyper-responsive to many stimuli, suggesting that SHP-1 may negatively regulate macrophage activation. Herein we report that the repressible/inducible over-expression of wild-type SHP-1 in a subclone of RAW 264.7 macrophages (RAW-TT10 cells) inhibited both TNF secretion and iNOS protein accumulation in response to stimulation with lipopolysaccharide (LPS) and recombinant murine interferon-gamma and led to diminished LPS-mediated tyrosine phosphorylation of vav1. In contrast, expression of a truncated SHP-1 construct previously shown to interfere with endogenous SHP-1 function modestly augmented LPS-mediated TNF and iNOS production and did not inhibit vav1 tyrosine phosphorylation. Taken together, these data provide the first direct evidence that SHP-1 inhibits macrophage activation by LPS and suggest that this effect may be mediated in part by dephosphorylation of vav1.
Insights
Protein tyrosine phosphatase SHP-1 negatively regulates macrophage activation. Overexpressing SHP-1 in macrophages inhibited TNF and iNOS production, suggesting SHP-1 dephosphorylates vav1 to control immune responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Protein tyrosine phosphatases (PTPs) like CD45 and SHP-1 are implicated in regulating macrophage activation.
- Mice deficient in SHP-1 exhibit hyper-responsive macrophages, suggesting a negative regulatory role for SHP-1.
Purpose of the Study:
- To provide direct evidence for SHP-1's inhibitory role in lipopolysaccharide (LPS)-induced macrophage activation.
- To investigate the molecular mechanisms underlying SHP-1-mediated regulation of macrophage activation.
Main Methods:
- Utilized a RAW 264.7 macrophage subclone (RAW-TT10 cells) for repressible/inducible overexpression of wild-type and truncated SHP-1.
- Stimulated macrophages with lipopolysaccharide (LPS) and recombinant murine interferon-gamma.
- Assessed Tumor Necrosis Factor (TNF) secretion and inducible Nitric Oxide Synthase (iNOS) protein levels.
- Analyzed LPS-mediated tyrosine phosphorylation of the vav1 protein.
Main Results:
- Overexpression of wild-type SHP-1 significantly inhibited LPS- and interferon-gamma-induced TNF secretion and iNOS accumulation.
- SHP-1 overexpression diminished LPS-mediated tyrosine phosphorylation of vav1.
- Expression of a dominant-negative truncated SHP-1 construct modestly increased TNF and iNOS production and did not affect vav1 phosphorylation.
Conclusions:
- SHP-1 directly inhibits LPS-induced macrophage activation.
- The inhibitory effect of SHP-1 may be mediated, in part, through the dephosphorylation of vav1.
- These findings elucidate a key regulatory mechanism in macrophage immune responses.
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
